Subject
Otorhinolaryngology,Oral Surgery,Pathology and Forensic Medicine,Surgery
Reference12 articles.
1. American Association of Oral and Maxillofacial Surgeons’ position paper on medication-related osteonecrosis of the jaw—2022 update;Ruggiero;J Oral Maxillofac Surg,2022
2. Fournier P, Boissier S, Filleur S, Guglielmi J, Cabon F, Colombel M, et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats, 62; 2002, p. 6538–44.
3. Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws and the factors affecting treatment outcome: a multicenter retrospective study with propensity score matching analysis;Hayashida;J Bone Min Res,2017
4. Surgical management of medication-related osteonecrosis of the jaw is associated with improved disease resolution: A retrospective cohort study;El-Rabbany;J Oral Maxillofac Surg,2019
5. Stage 3 medication-related osteonecrosis of the posterior maxilla: surgical treatment using a pedicled buccal fat pad flap: Case reports;Berrone;J Oral Maxillofac Surg,2015